Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['durva', 'bevacizumab', 'gyn', 'ovarian', 'olaparib']
durvalumab + standard upfront therapy w/ chemotherapy &amp; bevacizumab followed by maintenance bevacizumab, durvalumab, &amp; olaparib led to a statistically significant improvement in pfs in newly diagnosed, advanced ovarian cancer. #asco23 #asco2023 #gyncsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.